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Abstract
Background: Rapid eye movement sleep (REMS) is characterized by activation of the cortical and hippocampal
electroencephalogram (EEG) and atonia of non-respiratory muscles with superimposed phasic activity or twitching,
particularly of cranial muscles such as those of the eye, tongue, face and jaw. While phasic activity is a characteristic feature
of REMS, the neural substrates driving this activity remain unresolved. Here we investigated the neural circuits underlying
masseter (jaw) phasic activity during REMS. The trigeminal motor nucleus (Mo5), which controls masseter motor function,
receives glutamatergic inputs mainly from the parvocellular reticular formation (PCRt), but also from the adjacent
paramedian reticular area (PMnR). On the other hand, the Mo5 and PCRt do not receive direct input from the
sublaterodorsal (SLD) nucleus, a brainstem region critical for REMS atonia of postural muscles. We hypothesized that the
PCRt-PMnR, but not the SLD, regulates masseter phasic activity during REMS.
Methodology/Principal Findings: To test our hypothesis, we measured masseter electromyogram (EMG), neck muscle EMG,
electrooculogram (EOG) and EEG in rats with cell-body specific lesions of the SLD, PMnR, and PCRt. Bilateral lesions of the
PMnR and rostral PCRt (rPCRt), but not the caudal PCRt or SLD, reduced and eliminated REMS phasic activity of the masseter,
respectively. Lesions of the PMnR and rPCRt did not, however, alter the neck EMG or EOG. To determine if rPCRt neurons use
glutamate to control masseter phasic movements, we selectively blocked glutamate release by rPCRt neurons using a Cre-
lox mouse system. Genetic disruption of glutamate neurotransmission by rPCRt neurons blocked masseter phasic activity
during REMS.
Conclusions/Significance: These results indicate that (1) premotor glutamatergic neurons in the medullary rPCRt and PMnR
are involved in generating phasic activity in the masseter muscles, but not phasic eye movements, during REMS; and (2)
separate brainstem neural circuits control postural and cranial muscle phasic activity during REMS.
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Introduction
Rapid eye movement (REM; also termed paradoxical or active)
sleep in the rat is characterized by tonic phenomena including
desynchronization of the cortical electroencephalogram (EEG),
prominent hippocampal theta activity and postural muscle atonia
[1,2]. In addition, and superimposed on the background of tonic
postural muscle atonia during REM sleep, are phasic cranial
muscle twitches that include rapid eye movements and twitching
of the jaw, whisker and tongue muscles [3–6]. Given that the jaw
and tongue muscles may share similar neural control mechanism,
elucidating the neural mechanisms mediating phasic activation
and tonic inhibition of jaw muscles during REM sleep may help to
understand the neural control of the tongue muscle in sleep apnea
[7]. As a related example, suppression of postural muscle activity
during REM sleep prevents sleeping individuals from ‘acting out
their dreams’ as occurs in human REM sleep behavior disorder
(RBD) [8]. It has been recently shown that damage to the
sublaterodorsal nucleus (SLD) in rats and the subcoeruleus region
in human [9–12] results in the development of RBD. By contrast,
the neural circuits mediating both phasic activation and the tonic
inhibition of the cranial musculature during REM sleep remain
undetermined.
Mo5 is the largest cranial motor nucleus and has two functional
divisions: a ventromedial region containing motoneurons inner-
vating the jaw opening muscles and a dorsolateral region
containing the motoneurons of jaw closure [13]. The jaw-closing
masseter muscles exhibit prominent phasic activity during REM
sleep [14], which is blocked by reverse microdialysis of glutamate
receptor antagonists into Mo5 [5]. Mo5 receives glutamatergic
projections predominantly from the parvocellular reticular nucleus
(PCRt) but also a less dense input from the paramedian reticular
area (PMnR) [7,15]. We hypothesized that the PCRt and PMnR
are primary sources of glutamatergic input to the Mo5 that drive
phasic activity during REM sleep. We tested this hypothesis using
two experimental approaches. In the first experiment, we made
cell-body specific lesions in the rat SLD, PMnR and PCRt and
then recorded the EEG, neck electomyogram (EMG), masseter
EMG and electrooculogram (EOG). In the second experiment, we
used genetically modified mice to selectively eliminate glutama-
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8788tergic neurotransmission by rostral PCRt (rPCRt) neurons and
subsequently recorded the EEG, neck EMG and masseter EMG.
Results
Cell-Body Specific Lesions and Histology in Rats
We used anti-orexin-B IgG-saporin (OX-SAP) to produce cell-
body specific lesions in the rPCRt (rostral to the inferior olive and
posterior to the facial nerve) (Fig. 1B), SLD (Fig. 1C), caudal PCRt
(cPCRt) (Fig. 1D) and PMnR (Fig. 1E) (see Fig. 2A&D for location
of rostral and caudal PCRt). In the PCRt, SLD and PMnR, OX-
SAP killed most, if not all, neurons. The extent and boundaries of
the lesions were determined by Nissl staining (Fig. 1). All lesion
cases for the rPCRt, PMnR, SLD, and cPCRt are illustrated in
Figure 2, where we show the overlapping lesions at two levels of
each target structure.
The Effects of Lesion Sites on REM Sleep and Masseter
Phasic Activity in Rats
Similar to control rats (n=13), SLD (n=5), PMnR (n=5),
rPCRt (n=8) and cPCRt (n=4) lesioned rats exhibited a normal
diurnal rhythm of REM sleep, with higher levels during the light
period. No difference in daily REM sleep time was found between
the control and lesion groups (control: 7.560.3%, n=13; SLD:
8.060.5%, n=5, p=0.4; PMnR: 7.861.0%, n=5, p=0.8;
rPCRt: 6.660.4%, n=8, p=0.1; cPCRt: 7.160.4%, n=4,
p=0.4; individual t-tests between control and each lesion site).
Other motor activities including reflex activities, blinking and head
turning appeared normal during wakefulness in all groups.
Typical REM sleep from a control animal (Fig. 1A & a) was
characterized by a desynchronized EEG with increased power in
the theta range, atonia of neck and jaw (masseter) muscles, phasic
masseter twitches and rapid eye movements. As others have done
previously, we further divided the behavioral state of REM sleep
into two components [16–18]: tonic REM sleep, which consists of
constant atonia of the neck, masseter and ocular muscle (a single
muscle twitch may occasionally occur; Fig. 1a); and phasic REM
sleep, which is operationally defined as an epoch containing a
burst of muscle contractions superimposed on muscle atonia (see
Fig. 1A, arrows), and was primarily observed in the masseter and
extraocular EMG (Fig. 1A, a). To quantify EMG changes, we
recorded jaw and neck EMG at a high sampling rate (2000 Hz)
between 9:00 AM and 12:00 PM - a period during which REM
sleep is enriched [19,20]. During this period, only rPCRt lesioned
rats showed a significant increase of active wake at the expense of
all other stages (Fig. 3). When normalized to active wake, the neck
EMG showed a progressive decrease in muscle tone from active
wake to tonic REM sleep (Fig. 4A). During phasic REM sleep, the
neck muscles showed only a few phasic events (Fig. 1A) (phasic/
tonic EMG ratio=1.1560.04, n=10 controls; Fig. 4a). As with
postural muscles, masseter muscle tone decreased progressively
from active wake to quiet wake and to non-REM (NREM) sleep.
However, in contrast to postural muscles, no significant change in
tone was seen between NREM and tonic REM sleep (masseter
activity as a percentage of quiet wake activity: 17.162.1 vs
15.062.4% in NREM and REM sleep respectively, n=10
controls, p=0.52, Fig. 4B). In addition, during phasic REM
sleep, phasic activity in the masseter EMG occurred far more
frequently than in the neck EMG (masseter=3.9460.65 twitches/
s of phasic REM sleep; neck muscle=1.2860.43 twitches/s of
phasic REM sleep, n=10 control rats, p=0.005; Fig. 5).
As reported previously [9], rats with SLD lesions exhibited REM
sleep without atonia (i.e., jerking, twitching, jumping and running),
the animal equivalent of human RBD. However, we found that the
tonic and phasic activity of masseter EMG in the SLD lesioned rats
did not differ from that of controls (Fig. 1C). Moreover, the phasic
twitches seen in the masseter did not appear synchronized with the
neck EMG, nor with the EOG following SLD lesions. PMnR and
rPCRt lesions reduced and eliminated masseter phasic twitches,
respectively (Fig. 1E & B). Surprisingly, and in contrast to that seen
in rPCRt lesioned rats (Fig. 1B), cPCRt lesions had no effect on
masseter phasic activity during REM sleep (Fig. 1D). Finally, the
rapid eye movements of REM sleep were preserved in all lesion
groups, as determined from the EOG (Fig. 1).
In agreement with our observation using the slower 256Hz
sampling rate, EMG analysis at 2000 Hz showed that SLD lesions
significantly increased neck muscle tone as compared with
controls, particularly during phasic REM sleep (Fig. 4A & a).
However, SLD lesions did not affect the masseter EMG during
REM sleep (Fig. 4B & b). By contrast, lesions of the PMnR and
rPCRt did not significantly alter neck muscle EMG tone during
REM sleep but significantly reduced the ratio of phasic REM sleep
to tonic REM sleep masseter EMG compared with control
animals (1.1460.05 from n=8 rPCRt lesion group v. 1.4560.07
from n=10 control rats, p=0.0019; 1.1960.05 from n=5 PMnR
lesion group v. 1.4560.07 from n=10 control rats, p=0.012;
Fig. 4b). In addition, rPCRt lesions produced a larger, though not
statistically significant, decrease in phasic masseter tone than
PMnR lesions (1.1460.05 in 8 rPCRt lesioned rats vs 1.1960.05
in 5 PMnR lesioned rats, p=0.51; Fig. 4b). Additionally, SLD
lesions did not affect masseter phasic activity during REM sleep
but increased neck muscle phasic twitch frequency (24.1668.53
twitches/s of total REM sleep in 4 SLD lesioned rats vs 0.9860.33
twitches/s of total REM sleep in 10 controls, p=0.0009, Fig. 5).
PMnR and rPCRt lesions did not affect neck muscle twitch
frequency but significantly decreased masseter twitch frequency
(PMnR: 0.7760.32 twitches/s of total REM sleep, n=5, p=0.03
and rPCRt: 0.6460.25 twitches/s of total REM sleep, n=8,
p=0.002 vs 2.2360.38 twitches/s of total REM sleep in control,
n=10, Fig. 5). Consistent with the absence of an effect on neck
EMG, cPCRt lesions did not alter masseter tonic and phasic
activity during REM sleep (Fig. 4 & 5).
Finally, but for reasons that remain unclear, rPCRt lesions, but
not cPCRt lesions, resulted in a ca. 40% loss of body weight. The
loss of body weight observed in the rPCRt lesionsed animals could
be explained, at least in part, by a decrease in food intake, possibly
secondary to changes in masseter motor function. We cannot
however make a definitive and quantitative statement to this effect
as food intake was not measured in our study.
Genetic Disruption of Glutamatergic Neurotransmission
by rPCRt Neurons in Mice
An adeno-associated viral (AAV) vector containing Cre-
recombinase (AAV-Cre) was injected into the rPCRt of transgenic
mice with lox-P sites flanking the second axon of the vesicular
glutamate transporter 2 gene (VGLUT2-flox). This resulted in a
complete loss of VGLUT2 mRNA in the mouse rPCRt (Fig. 6A),
as determined by in situ hybridization. By contrast, vector control
injections of an AAV containing Green Fluorescent Protein (AAV-
GFP) did not result in any changes in VGLUT2 mRNA levels
(Fig. 6B). Importantly, the regional loss of in situ signal overlapped
with Cre immunolabeling (Fig. 6a). Analysis of EEG and masseter
EMG (EMG-J) recordings showed that selective elimination of
glutamate release from rPCRt neurons produced a significant
reduction in phasic masseter activity during REM sleep, similar to
cell-body specific lesions in the rPCRt (Fig. 6C). VGLUT2
deletion in the rPCRt did not however significantly alter the 3 h
(9am-12pm) sleep-wake distribution as compared to control AAV-
REM Sleep Masseter Twitches
PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8788Figure 1. Lesion histology and REM sleep phenotype following cell-body specific lesions in rats. (A) unlesioned control, the arrows show
masseter twitches (EMG-J) and bursting in the EOG during REM sleep (B) rPCRt lesion (OX-SAP,0.1%, 330 nl; rPCRt is defined as the portion of PCRt
that is rostral to the inferior olive and caudal to the facial tract; cPCRt extends caudally from this), (C) SLD lesion (OX-SAP,0.1%, 130 nl), (D) cPCRt
lesion (OX-SAP,0.1%, 330 nl) and (E) PMnR lesion (OX-SAP,0.1%, 230 nl). For each experimental condition a 2 min REM sleep episode example (from
the 256 Hz recording) is shown to illustrate the typical EEG, EMG-neck, EMG-jaw and EOG recordings. A set of extended recording examples (from the
256 Hz recording) is showed in the lower right panel and includes: a) control, b) rPCRt lesion and c) SLD lesion cases. Note that during REM sleep, (1)
control rats showed activated EEG, EMG-N atonia, EMG-J phasic twitches and rapid eye movements; (2) rPCRt and PMnR lesions eliminated/reduced
EMG-J twitches; (3) SLD lesions increased phasic activity of the neck muscles; and (4) cPCRt lesion did not alter the REM sleep EEG/EMGs/EOG. SLD:
sublaterodorsal nucleus; PCRt: parvocellular reticular nucleus; PMnR: paramedian reticular area; PB: parabrachial nucleus; Ve: vestibular nucleus; 7:
facial nucleus; IO: inferior olive; EEG: electroencephalogram; EMG-N: neck electromyogram; EMG-J: masseter or jaw electromyogram; EOG:
electrooculogram; tR: tonic REM sleep; pR: phasic REM sleep.
doi:10.1371/journal.pone.0008788.g001
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PLoS ONE | www.plosone.org 3 January 2010 | Volume 5 | Issue 1 | e8788Figure 2. Lesion maps for all rPCRt(A), PMnR(B), SLD(C) and cPCRt (D) cases in rats. 5N: trigeminal nucleus; 6: abducens nucleus; 12:
hypoglossal nucleus; g7: facial nerve; IO: inferior olive; Py: pontine nuclei.
doi:10.1371/journal.pone.0008788.g002
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(integrated EMG-J) values during REM sleep were decreased in
VGLUT2 deleted mice (17.260.9% of wake, n=4, p=0.016), as
compared to controls (23.162.0% of wake, n=3; Fig. 7B).
Similarly, the masseter integral ratio of NREM and REM sleep
was significantly increased in the VGLUT2 deleted group when
compared to the control group (1.2860.04 vs 0.9660.11 in
control, p=0.034; Fig. 7C). Finally, VGLUT2 deletion in the
rPCRt resulted in the loss of masseter twitches during REM sleep
(0.1260.02 vs 3.5961.12 Hz in control, p=0.027; Fig. 7D).
Similar to the rPCRt lesionsed rats, body weight was significantly
decreased following VGLUT2 deletion (ca. -16%; 21.060.7 g,
2761.2 days after AAV-cre injection, n=4 v. 25.060.6 g, 3361.5
days after AAV-GFP injection, n=3; p=0.009).
Discussion
Here we report that, in rats, cell-body specific lesions in the
rPCRt and PMnR, but not cPCRt, significantly reduced masseter
phasic activity during REM sleep without affecting neck muscle
activity. By contrast, cell-body specific lesions in the SLD
produced jerking and twitching of postural muscles (i.e., REM
sleep without atonia; as reported previously, [9]), but did not affect
masseter (tonic or phasic) activity during REM sleep. None of the
lesions affected daily REM sleep time or rapid eye movements, i.e.
EOG activity. AAV-Cre mediated deletion of the VGLUT2 gene
in the rPCRt, and hence glutamate release by rPCRt neurons,
resulted in the near complete elimination of masseter twitches
during REM sleep in mice. These results indicate that, during
REM sleep: (1) different neural circuits mediate twitches (phasic)
and atonia (tonic) events in the masseter; (2) different neural
circuits are involved in masseter (cranial muscle) and neck muscle
(postural muscle) twitch control; (3) different neural circuits are
involved in generating rapid eye movements and masseter twitches
(i.e., two separate cranial muscle control systems); and (4)
glutamatergic rPCRt premotoneurons mediate masseter twitches.
Circuitry Controlling Cranial and Postural Motor Systems
during REM Sleep
Parsing muscle function into two separate processes, tonic
(atonia) and phasic (muscle twitches), facilitates an understanding
Figure 3. Three hours (9am-12pm) sleep-wake distribution
following cell-body specific lesions in rats. Percentage of time of
AW: active wake, QW: quiet wake, NR: non REM sleep, tR: tonic REM
sleep, pR: phasic REM sleep and MT: artifacts during the 3 h, 2 kHz
recording for EMG analysis. All values are means 6 SEM; *p,0.05 using
a two-tailed t-test.
doi:10.1371/journal.pone.0008788.g003
Figure 4. Neck muscle and masseter activity following cell-
body specific lesions in rats. In A (neck) and B (jaw), muscle activity
for each stage is expressed in percentage of the active wake muscle
activity (left panel). a and b (right panel) represent corresponding ratios
of phasic and tonic REM sleep muscle activity. AW: active wake; QW:
quiet wake; NR: non REM sleep; tR: tonic REM sleep; pR: phasic REM
sleep. All values are means 6 SEM; *p,0.05 using a two-tailed t-test.
doi:10.1371/journal.pone.0008788.g004
Figure 5. Neck muscle and masseter twitches during REM sleep
following lesions in rats. Y axis=number of muscle twitches/REM
sleep time (s). Note that SLD lesion significantly increase neck muscle
twitches while both PMnR and rPCRt lesions significantly decrease
masseter twitches, as compared with the control groups. EMG-J: jaw or
masseter electromyogram; EMG-N: neck electromyogram; R: total REM
sleep; All values are means 6 SEM; *p,0.05; **p,0.01; ***p,0.001
using a two-tailed t-test.
doi:10.1371/journal.pone.0008788.g005
REM Sleep Masseter Twitches
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and cranial motor systems during REM sleep. While the general
consensus is that GABA, glycine and monoamines contribute to
atonia (i.e., non-phasic) control [21–26], the precise role of these
neurotransmitter systems has not been resolved, and the neural
circuitry responsible for atonia has not yet been elaborated.
As compared to atonia control, the neural basis of phasic
control is much better understood. One aspect of phasic control
that appears to be conserved between cranial and postural muscles
is the role of glutamate in driving phasic activity (the present study
and [27]). By contrast, unconserved aspects of cranial and postural
phasic control include: 1) the involvement of different glutama-
tergic sources and neural circuits; and 2) that glycine appears to
inhibit phasic activity in postural muscles [21], while glycine is
unable to suppress phasic activity in cranial motor systems [28].
For instance, infusion of GABA-A and glycine receptor antagonists
into Mo5 increases phasic activity of the masseter during REM
sleep [28]. These data suggest that, unlike postural motor systems,
Mo5 (and possibly other cranial motor nuclei) may lack active
mechanisms for suppressing phasic activity. Postural muscle phasic
activity is more completely suppressed during REM sleep,
although this varies by age, species and in some neurodegenerative
disorders that result in RBD [8]. Our laboratory has previously
identified glutamatergic SLD and supraolivary medulla (SOM)
[9,27] neurons that are involved in the phasic control of postural
muscles. In the present study we show that the neurons of the
rPCRt and PMnR mediate masseter phasic activity during REM
sleep, and that this regulation occurs via glutamatergic projections,
at least from the rPCRt.
Medullary Neural Circuitry Regulating Tonic and Phasic
Activity in Cranial Muscles during REM Sleep
We have identified two brainstem premotor areas, the PMnR
and PCRt, which are involved in generating masseter twitches
during REM sleep. Interestingly, cell-body specific lesions of these
regions had no effect on masseter atonia, indicating that Mo5
premotoneurons in these regions are not involved in generating
masseter atonia during REM sleep. It is therefore likely that
separate neural circuits are responsible for producing tonic and
phasic phenomena in the masseter EMG during REM sleep.
Recently, it was suggested that cholinergic and monoaminergic
systems may be involved in generating tonic atonia in cranial
motor systems [18,29,30]. During REM sleep, Mo5 neurons
receive large amplitude inhibitory postsynaptic potentials (IPSPs)
[31], most likely mediated by GABA and glycine, which result in
masseter atonia, though these conclusions remain controversial
[28]. Fenik and colleagues have also proposed an alternative
hypothesis in which the loss of monoamines (norepinephrine and
serotonin) release is likely responsible for the reduction in tonic
muscle tone during REM sleep [23].
While atonia occurs in almost all non-respiratory muscles
during REM sleep, phasic activity occurs primarily in cranial
muscles and those of the extremities. In the present study, visual
observation of the recording traces evidenced no temporal
synchronization between phasic masseter and neck phasic EMG
activity (SLD lesions) and, furthermore, no temporal synchroni-
zation was apparent among neck, jaw and ocular muscles in
control rats. By contrast, postural muscle twitching (such as neck
and leg) appeared synchronized in SLD lesioned animals (Lu,
Figure 6. Selective elimination of glutamate release from the rPCRt. Injections (boxes in upper right corners) of AAV-Cre or AAV-GFP
encompassing the rPCRt are shown by Cre (a, knockout) or GFP (b, control) immunostaining in a floxed Vglut2 mouse. VGLUT2 mRNA signal (black
puncta) in an AAV-Cre injected mouse (A) and AAV-GFP injected mouse (B) in the region corresponding with Cre or GFP immunolabelling in the
Vglut2 mouse. Note the loss of VGLUT2 mRNA in the Cre, but not GFP, injected animal. C&D , EEG, EMG-Neck and EMG-Jaw traces during REM sleep
in an AAV-Cre injected VGLUT2 floxed mouse (C) and AAV-GFP (vector control) injected VGLUT2 floxed mouse (D). Specific elimination of Vglut2 from
the rPCRt neurons resulted in reduced phasic masseter twitches during REM sleep.
doi:10.1371/journal.pone.0008788.g006
REM Sleep Masseter Twitches
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control (excitation and inhibition) originates from a common
source (i.e., the SLD) while cranial phasic control likely originates
from multiple, discrete sources. While it is not clear what the
generator of phasic activity might be for postural muscles, we
speculate that it is comprised of local glutamatergic neurons in the
spinal cord. Nevertheless, we do know that SLD glutamatergic
neurons are involved in preventing the occurrence of phasic
movements of postural muscles [32,33]. Our results suggest that
the cell populations driving cranial muscle twitching during REM
sleep are probably situated close to the relevant motor nuclei.
The PCRt contains cholinergic, GABAergic/glycinergic and
glutamatergic neurons, topographically targeting the hypoglossal,
facial and trigeminal motor nuclei [34]. However, the glutama-
tergic (VGLUT2-positive) population constitutes the largest
population of premotor neurons targeting Mo5 [7] and results
from the present study demonstrate that glutamate released from
PCRt neurons drives Mo5 phasic activity. As the PCRt also
contains glutamatergic premotor neurons for facial (Mo7) and
hypoglossal nuclei (Mo12) [7], we speculate that glutamatergic
neurons in the PCRt may drive phasic activity of Mo7 and Mo12
during REM sleep. Notably, none of the lesions produced changes
in phasic EOG activity, suggesting that premotor neurons involved
in generating rapid eye movements are not located in the PCRt,
PMnR or SLD. Finally, the identities of the inputs that activate the
rPCRt/PMnR neurons during REM sleep remain unresolved.
In conclusion, we have identified that glutamatergic neurons of
the PCRt-PMnR provide critical inputs to Mo5 for the regulation
of phasic masseter activity during REM sleep, although whether or
not these putative premotor neurons are sufficient for eliciting or
timing this phasic activation remains to be determined. In
addition, rPCRt-PMnR putative premotor neurons are not
similarly involved in the regulation of atonia or phasic activity of
the extraocular and neck muscles, further suggesting that separate
neural circuits mediate phasic and tonic atonia of cranial and
postural muscles during REM sleep.
Materials and Methods
Experiment 1: Lesion Studies in Rats
Animals. Pathogen-free, adult, male Sprague-Dawley rats
(275–300 grams, Harlan) were individually housed at 20–22uCo n
a 12:12 light-dark cycle (lights on at 07:00 A.M.), with food and
water available ad libitum. The rats were housed in the Harvard
Animal Research Facility and the care of animals used in this study
met National Institutes of Health standards, as set forth in the
Guide for the Care and Use of Laboratory Animals and was
approved by the Beth Israel Deaconess Medical Center and
Harvard Medical School Institutional Animal Care and Use
Committees.
Lesions. Because ibotenic acid injection in the medulla
produces almost 100% mortality in rats (Lu, unpublished data),
in this study, we used anti-orexin-B IgG-saporin (OX-SAP) to
produce cell-body specific lesions in different brain areas. OX-SAP
is designed to specifically target and kill neurons that express
orexin2 (OX2) receptors. Given that OX2 receptors are widely
distributed in the brain [35], OX-SAP is capable of producing cell
death in most CNS regions. Selectivity is evident at moderate
doses (0.05%), with destruction of neurons in the
tuberomammillary nucleus and non-cholinergic neurons in the
basal forebrain and pontine tegmentum [29]. At higher doses
(0.1%), however, OX-SAP may also kill neurons that contain
either low levels of OX2 receptors or none at all, such as basal
forebrain cholinergic neurons ([27] & Fuller and Lu, unpublished
data). However, some regions that lack OX2 receptors, such as the
suprachiasmatic nucleus and thalamus are almost completely
resistant to the toxic effect of OX-SAP, even at very high
concentrations (Lu, unpublished data).
After the animals were anesthetized with chloral hydrate (7% in
saline, 350 mg/kg, intra peritoneal), the rats were placed in
stereotaxic apparatus, the skull was exposed and a small
craniotomy was made. A fine glass pipette [1 mm glass stock,
tapering slowly to a 10–20 mm tip] containing anti-orexin-B IgG-
saporin (0.1% solution, Advanced Targeting Systems, CA) was
then lowered to one of the four predetermined targets, including:
sublaterodorsal nucleus [SLD, anteroposterior (AP) 29.24 mm,
lateral (L)61.2 mm, dorsoventral (DV) 26.4 mm, 130 nl], rostral
parvocellular reticular nucleus [(rPCRt), AP -10.5 mm,
L62.1 mm, DV -7.2 mm, 330 nl], paramedian reticular area
[(PMnR) AP -12.8 mm, L 0.0 mm, DV -8.2 mm, 230 nl] and
caudal parvocellular reticular nucleus [(cPCRt), AP -12.3 mm,
L62.0 mm, DV -6.3 mm, 330 nl] as per the rat atlas of Paxinos
and Watson (2005; [36]). The orexin-SAP was injected using a
compressed air delivery system described previously [37,38]. In
brief, the meniscus within the pipette was directly visualized with
an operating microscope, and fluid was ejected using brief puffs of
air at 50 lb/ft
2. These air puffs were regulated by an electronically
controlled air switch, which opened for 5–10 ms every 0.5–1 s.
These variables were adjusted for each pipette such that 130–
330 nl was injected over a 2-min period. The injected volume was
Figure 7. Sleep-wake and masseter activity analysis following
loss of rPCRt glutamate release. (A) Percentage of W: wake, NR:
non REM sleep, R: REM sleep and MT: artifacts from the 2 kHz recording
for EMG (3 hours, 9AM-12PM). (B) Masseter activity of each stage
expressed as a percentage of wake masseter activity in AAV-Cre and
AAV-GFP (control) injected mice. (C) Ratio of NR and REM sleep
masseter activity in AAV-Cre and AAV-GFP injected mice. (D) masseter
twitches during REM sleep in AAV-Cre and AAV-GFP injected mice. Y
axis=number of muscle twitches/REM sleep time (s). All values are
means 6 SEM; *p,0.05 using a two-tailed t-test.
doi:10.1371/journal.pone.0008788.g007
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within the pipette with a reticule on the microscope. After the
brain injection, animals were implanted by EEG/EMGs/EOG
electrodes.
EEG/EMG leads implantation. Four electroen-
cephalogram (EEG) screw electrodes (Plastics One) were
implanted into the skull, in the frontal (2) and parietal bones (2)
of each side. Two flexible electromyogram (EMG) wire electrodes
(Plastics One, stock # E363/76) were placed into the neck muscles
via a small needle hole and two additional flexible EMG wire
electrodes (Plastics One, stock # E363/76) were placed into the left
masseter. For lead placement in the masseter, the muscle was
exposed with a small incision in the skin of the left jaw, the head of
the electrodes were introduced into the masseter via a small needle
hole and the wires were tunneled subcutaneously along the dorsal
surface of the cranium. The remaining two flexible EMG wire
electrodes (Plastics One, stock # E363/76) were positioned in the
medial and lateral canthi of the right eye for recording the
electrooculogram (EOG). Each EMG electrode was securely fixed
with 0.5 ml of tissue adhesive (LiquiVet, Oasis Medical Mettawa,
Illinois). Finally, the free ends of the leads were connected to two
pedestal sockets (6 pin connector, Plastics One) and the assembly
was fixed in place with dental cement. The scalp wound was closed
with surgical clips, and the rat was kept in a warm environment
until resuming normal activity. The entire procedure was
completed in 60–90 min.
Sleep-wake recording. One week after surgery, the sockets
were connected via flexible recording cables and a commutator
(Plastics One) to an analogue amplifier (A-M Systems) and
computer, with an analogue to digital converter card and
running VitalRecorder (Kissei, Japan). EEG/EMGs/EOG was
recorded at the end of the second post-surgical week for two
separate 36 h recording sessions, beginning at 7:00 P.M. and at a
sampling rate of 256 Hz (daily sleep-wake cycle analysis) and for
two separate 3 h recording sessions, beginning at 9:00 A.M. and at
a sampling rate of 2000 Hz (EMG analysis). No filter was applied
for any recording. During each recording session, the animals
were left undisturbed.
Perfusion and histology. At the end of each experiment,
animals were deeply anesthetized by chloral hydrate (7% in
saline, 500 mg/kg, intra peritoneal), and perfused though the
heart with 50 ml saline followed by 500 ml 10% formalin in
phosphate buffer saline (PBS). The brains were removed, post-
fixed in 10% formalin in PBS overnight, equilibrated in PBS
containing sodium azide (0.02%) (PBS-Azide) and sucrose (20%)
for 3 days, and then sectioned at 40mm on a freezing microtome
in four series. Brain sections were mounted, dried, stained with
thionin, dehydrated and coverslipped. Tissue sections were
viewed using a light microscope and the location of the lesions
was plotted on standardized brain maps [30] to verify the lesion
localizations.
Control group. Six rats without any brain injection were
implanted with EEG/EMG-neck/EMG-masseter/EOG to study
normal REM sleep muscle phenotypes. Four rPCRt and three
SLD OX-SAP injected rats failed to display any REM sleep
phenotype and subsequent Nissl staining confirmed that these
animals also did not have lesions in these or other areas. Because
the results from both non-injected and non-lesioned rats were not
statistically different, they were pooled together and are reported
as one control group. In addition, three rats within the control
group had considerable heart muscle activity artifacts in the EMGs
recordings. Therefore these rats were include in the sleep-wake
time analysis (n=13 controls) but were excluded from the EMG
analysis (n=10 controls).
Behavioral states. Three behavioral states (Wake, NREM
and REM sleep) were visually identified and analyzed in 10-s
epochs for daily sleep-wake cycle analysis (sampling rate: 256 Hz);
six behavioral states (AW, QW, NR, tR, pR and MT; see below)
were visually identified and analyzed in 4-s epochs for the EMG
analysis (sampling rate: 2000 Hz) using SleepSign for Animal
(Kissei, Japan). Classification of behavioral states was as follows:
active wake (AW), characterized by high frequency, low-voltage
EEG signals coupled with high levels of EMG activity (i.e.,
chewing, grooming, drinking); quiet wake (QW), characterized by
high-frequency, low-voltage EEG signals and an absence of overt
motor activity or a change in sleeping position coupled with a
minimum of 4-s EEG activation; NREM sleep (NR) was
characterized by high-amplitude, low-frequency EEG signals and
the absence of motor activity; tonic REM sleep (tR) was
characterized by low-amplitude, high-frequency theta-like EEG
activity and neck and jaw muscle atonia, when muscle twitches
and rapid eye movements are conspicuously absent, episodes
included isolated muscle twitch and/or isolated eye movement
where scored as tR; phasic REM sleep (pR) was characterized by
low-amplitude, high-frequency theta-like EEG activity and neck
and jaw muscle atonia interspersed by periodic burst of muscle
twitches and/or burst of rapid eyes movements during more then
50% of the 4-s epoch. State transitions, sleep jumps or positional
changes associated with an activated EEG shorter than 4-s were
removed from the analysis and scored as artifact (MT).
EMG analysis. REM sleep consists of both tonic and phasic
motor events. Tonic REM sleep constitutes the stereotypical
periods of motor atonia during REM sleep while phasic REM
sleep constitutes the periodic muscle twitches that punctuate REM
sleep (i.e., during rapid eye movements) [3,6]. Because a major
goal of this study was to determine the importance of SLD, PMnR
and/or PCRt projections in modulating motor activity in REM
sleep, we developed an objective method for quantifying the tonic
(i.e., REM sleep atonia) and phasic (i.e., muscle twitches) periods
of REM sleep. To quantify muscle tone, raw EMG signals were
filtered between 0–10 Hz in SleepSign for Animal using a high
pass filter, which eliminated body movement artifacts, and were
full-wave rectified, integrated, and quantified in arbitrary units, for
every 4-s epoch, using the ‘‘integral’’ function of SleepSign for
Animal. Then all measurements were normalized as mean activity
during all of AW being 100% (Fig. 4A&B) or as mean activity
during all of tR being 1 (Fig. 4a&b). The muscle twitches that
define phasic REM sleep were detected as motor events that
exceeded at least two times the amplitude of EMG activity during
tonic REM sleep. In both lesioned and control rats, muscle
twitches were quantified by 4-s epochs for each REM sleep
epochs, using the ‘‘cross level’’ function of SleepSign for Animal.
Experiment 2: Genetic Deletion of the Vesicular
Glutamate Transporter 2 (VGLUT2) Gene from the rPCRt
in Mice
Microinjection and recordings. Experiment 2 was
performed using mice with loxP sites flanking exon-2 of the
Vglut2 gene (n=7). To selectively eliminate glutamate
neurotransmission by rPCRt neurons in these mice, we injected
an adeno-associated viral (AAV) vector expressing Cre
recombinase (Cre) into the rPCRt (AP=25.5, DV=24.5,
RL=61.3 mm; [39]) (n=4). When exposed to Cre, the second
exon of the VGLUT2 gene was deleted, rendering the Cre-
infected neurons incapable of expressing functional protein and
hence preventing vesicular neurotransmitter (glutamate) packaging
and subsequent release of glutamate from rPCRt neurons [40]. As
vector injection controls, we injected AAV expressing green
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Injections of AAV-Cre or AAV-GFP into the rPCRt of these mice
were done using a compressed air delivery system [37,41]. After
injections of either AAV-Cre (60 nL) or AAV-GFP (60 nL), mice
were implanted by EEG/EMG-neck/EMG-masseter electrodes.
Three EEG screw electrodes (Pinnacle Technology Inc., Kansas)
were implanted into the skull, in the parietal (n=1) and frontal
(n=2) bones of each side. One flexible EMG wire electrode
(Plastics One) was placed between the neck muscles and two
additional flexible EMG wire electrodes (home-made with Cooner
Wire, California; head diameter=1 mm) were placed into the left
masseter. For implanting the masseter EMG, a small incision was
made in the skin of the left jaw, the head of the electrodes were
introduced into the masseter via a small needle hole, the leads
were securely fixed with 0.2 ml of tissue adhesive (LiquiVet, Oasis
Medical Mettawa, Illinois) and the wires were tunneled
subcutaneously along the dorsal surface of the cranium. The free
ends of the leads were connected to a connector (Pinnacle
Technology Inc.) and the assembly was fixed in place with dental
cement. Three weeks after surgery, the connector was connected
via a flexible recording cable, preamplifier and commutator to an
analogue amplifier (Pinnacle Technology Inc.) and computer.
Following a one-week habituation period to the recording box and
cabling, EEG/EMGs were recorded for two separate 24 h
recording sessions, beginning at 7:00 P.M. at a sampling rate of
400 Hz and two separate 3 h recording sessions, beginning at 9:00
A.M. at a sampling rate of 2000 Hz. During each recording
session, the animals were left undisturbed. In brief, the EEG was
recorded contralaterally in the fronto-parietal cortex, EMG-Jaw
was recorded using the EMG channel of Sirenia (Pinnacle
Technology Inc.), EMG-Neck was recorded between the parietal
EEG electrode and the neck EMG electrode and was used to assist
in the scoring of the data, although the EMG signal was not
included in the analysis.
Analyses of mouse sleep–wakefulness and quantification of
EMG were similar to that used for the rat recordings, including the
use of SleepSign for Animal.
In situ hybridization and immunohistochemistry. On
completion of the recordings, mice were deeply anesthetized with
chloral hydrate and perfused transcardially with saline (50 ml)
followed by 10%formalin in phosphate buffer saline(PBS) (200 ml).
The brains were removed, post-fixed in 10% formalin in PBS
overnight, equilibrated in PBS containing sodium azide (0.02%)
(PBS-Azide) and sucrose (20%) for 3 days, and then sectioned at
40 um on a freezing microtome in two series. One series from each
brain was processed for VGLUT2 in situ hybridization and the
other one for Cre-immunohistochemistry [42]. One series of
sections from the animals that received AAV-GFP were processed
for GFP-immunohistochemistry as described previously [9], instead
of Cre-immunohistochemistry. For the in situ hybridization, sections
were acetylated and hybridized overnight (55uC) with a
35S-labeled
cRNA probe synthesized from a plasmid containing the complete
coding sequence of VGAT or VGLUT2. After a succession of one
hour washes (2xSSC/1 mM DTT, 50uC; 0.2xSSC/1 mMDTT,
55uC; 0.2xSSC/1 mM DTT, 60uC), the tissue was treated with
RNase-A and washed under conditions of increasing stringency,
including a 30 min wash at 60uC in 0.1xSSC. The tissue was then
dehydrated in alcohols and air-dried. The sections were exposed to
X-ray film (Eastman-Kodak) for 2–3 days, and then the slides were
dipped in Kodak NTB-2 emulsion and exposed for one month.
Slides were developed in Kodak D-19, fixed, and then dehydrated
and coverslipped. For Cre- or GFP-immunohistochemistry,
sections were washed in phosphate buffer saline containing triton
(0.25%) and sodium azide (0.02%) (PBST-Azide) and then
incubated in primary antiserum (Cre antibody, Novagen or GFP
antibody, Invitrogen, both at 1:20,000 in PBST-Azide) for two days
at room temperature. Sections were then washed in PBST and
incubated in biotinylated secondary antiserum (against rabbit IgG,
1:1000 in PBST, Vector) for two hours, washed in PBST and
incubated in ABC regents for two hours. Sections were then washed
again and incubated in solution of 0.06% 3,3-diaminobenzidine
tetrahydrochloride (DAB, Sigma) and 0.02% H2O2.
Experiment 1 and 2
Statistical methods. Statistical differences in sleep-wake
time and muscle tone or twitches were assessed using a Student’s
two-tailed t-test, after a normal distribution was confirmed for
each group and a test for variance homoscedasticity was
performed. p,0.05 was considered significant.
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